logo

COVID-19: Drugs in Development

Share

The COVID-19 outbreak, which started in December 2019 in Wuhan City, China, was declared a "Public Health Emergency of International Concern" by the WHO on January 30, 2020. The outbreak was characterized as a pandemic on March 11, 2020.

Currently, there are no drugs to treat COVID-19, caused by the novel coronavirus SARS-CoV-2.

Listed below are companies that are in the race to find a treatment or vaccine for the novel coronavirus.

Subscribe to RTT Intelligent Investor for complete access to COVID-19 Drugs in Development Calendar.

Company Name
Drug
Current Stage
Next Milestone
Collaboration
Last Updated
Eusa Pharma
Siltuximab (repurposed for COVID-19)
Papa Giovanni XXIII Hospital sponsored SISCO Study in Italy; Encouraging interim data reported on Apr.1
-
-
04/01/2020
FUJIFILM Holdings Corporation
(FUJIF.PK, FUJIY.PK)
Avigan
A Phase III trial of Avigan in Japan for patients with COVID-19 initiated on Mar.31
Study completion in June, 2020
-
04/01/2020
InflaRx N.V.
(IFRX)
IFX-1
Initiated clinical trial of IFX-1 in patients with severe COVID-19-induced pneumonia in Netherlands on Mar.31
-
Beijing Defengrei Biotechnology Co. Ltd.
04/01/2020
Eli Lilly And Co.
(LLY)
Antibody therapeutics for treatment and prevention of COVID-19
Preclinical
Begin clinical trial in patients within the next four months
Privately-held AbCellera Biologics Inc.
03/29/2020
AIM ImmunoTech Inc.
(AIM)
Ampligen
Has been studied in SARS-infected mice earlier
To enter clinical trials as both a protective prophylaxis and an early-onset therapy for COVID-19
Japan's National Institute of Infectious Diseases (NIID) as well as the University of Tokyo
03/26/2020
OyaGen
OYA1
In lab-based assay, it demonstrated strong dosedependent antiviral activity against live SARS-CoV-2
Further studies for the safety and efficacy of OYA1 in treating COVID-19 are planned
National Institute of Allergy and Infectious Diseases
03/27/2020
Gilead Sciences Inc.
(GILD)
Remdesivir
Phase III trials in adults diagnosed with COVID-19 in China and U.S.
Phase III China trial results in April
Not Known
03/27/2020
Tonix Pharmaceuticals Holding Corp.
(TNXP)
TNX-801
Preclinical
Not Known
Southern Research
03/27/2020
Moderna, Inc
(MRNA)
mRNA-1273
Phase I trial in healthy volunteers
Phase I results by June 2021
CEPI, NIH
03/27/2020
APEIRON Biologics AG
APN01
Pilot investigator-initiated clinical trial in China launched
Phase 2B clinical trial
Not Known
03/26/2020
Buy this Content
Editors Pick
Drugstore chain Walgreens and courier services provider Postmates said they have expanded on-demand delivery to more than 7,000 Walgreens stores nationwide. The companies expect the service will help capitalize on the rising need for home delivery amid the coronavirus pandemic. The expansion will enable consumers in cities across the country to get home delivery of health and wellness items. A growing number of retailers in the U.S. are furloughing their employees as the coronavirus pandemic has resulted in the temporary closure of retail stores nationwide. The store closures came as more people in the U.S. are forced to remain at home to help curtail the spread of COVID-19 by promoting social distancing. Ride-hailing giant Uber Technologies said it is offering 10 million free rides and food deliveries to healthcare workers, seniors, and people in need, amid the surging coronavirus or covid-19 crisis. Across the world, the company aims to work with more cities, food banks, hospitals and others to move what matters, such as getting first responders to work, and food to those who need it.
>